Divi's Laboratories Ltd. (DIVISLAB)
BSE
9,032.05
+352.05 (+4.06%)
Closed
Aug 26, 2026
Day's Range
8,703.859,033.15
52 wk Range
5,637.509,033.15
Financial Statements - DIVISLAB - Divi's Laboratories Ltd.
Revenue
104.76B▲ 12.3%
Net Income
25.68B▲ 17.2%Net Margin 24.5%
EBITDA
39.44B▲ 18.8%
Free Cash Flow
2.18B▲ 1.4%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 104.76B | 93.25B | 77.96B | 76.65B | 87.99B | 68.58B |
| Cost of Goods | 42.81B | 38.70B | 32.69B | 31.78B | 30.91B | 24.32B |
| Gross Profit | 61.95B | 54.55B | 45.27B | 44.87B | 57.07B | 44.25B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 29.79B | 25.71B | 18.32B | 20.27B | 35.73B | 26.15B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 33.88B | 29.16B | 21.63B | 23.69B | 36.83B | 26.66B |
| Income Tax | 8.20B | 7.25B | 5.63B | 5.45B | 7.23B | 6.81B |
| Net Income | 25.68B | 21.91B | 16B | 18.24B | 29.60B | 19.84B |
| EPS Basic | 96.75 | 82.53 | 60.27 | 68.69 | 111.52 | 74.75 |
| EPS Diluted | 96.75 | 82.53 | 60.27 | 68.69 | 111.52 | 74.75 |
| Basic Shares Outstanding | 265.46M | 265.46M | 265.46M | 265.46M | 265.46M | 265.46M |
| Diluted Shares Outstanding | 265.46M | 265.46M | 265.46M | 265.46M | 265.46M | 265.46M |
| Ebit | 34.11B | 29.18B | 21.66B | 23.69B | 36.83B | 26.66B |
| Ebitda | 39.44B | 33.19B | 25.43B | 27.08B | 39.97B | 29.25B |
| Net Income Continuous Operations | 33.88B | 29.16B | 21.63B | 23.69B | 36.83B | 26.66B |
| Minority Interests | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
